LONDON, July 19, 2018 /PRNewswire/ -- The Cardiac electrophysiology mapping, navigation and recording devices are used to assess the timing and propagation of cardiac electrical activity, which are obtained using multiple intravascular electrode catheters positioned at various locations within the heart.
Download the full report: https://www.reportbuyer.com/product/5476601 According to IQ4I analysis, the cardiac electrophysiology mapping, navigation and recording devices global market is expected to grow at mid single digit CAGR to reach
$1,447.3 million by 2024. The cardiac EP mapping, navigation and recording devices market is mainly segmented by products, end-users and by geography. Cardiac EP mapping, navigation and recording devices by products is segmented into mapping and navigation systems, mapping catheters and navigation catheters, recording systems and accessories. Among the products, recording systems hold the highest share in 2017 and expected to grow at low single digit CAGR to reach $519.5 million by 2024. Mapping and Navigation Catheters segment is expected to grow at a high CAGR from 2017 to 2024. The mapping systems and navigation systems segment is further segmented by mapping system type as contact mapping systems and non contact mapping systems. The contact mapping segment holds the highest share of 70.5% in 2017 and expected to grow at mid single digit CAGR from 2017 to 2024.End-Users of Cardiac EP mapping, navigation and recording devices are segmented into hospitals, cardiac & ambulatory surgical centres and academics & research institutes. The hospital segment commanded the largest revenue in 2017 and expected to grow at mid CAGR during the forecasting period. Cardiac & ambulatory surgical centres segment is expected to grow at a strong CAGR from 2017 to 2024.The Cardiac EP mapping, navigation and recording devices global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue in 2017 and Asia-Pacific is expected to grow at highest CAGR during the forecasting period.Some of the major players in Cardiac EP mapping, navigation and recording devices market include Abbott Laboratories (St Jude Medical) (U.S.), Boston Scientific (U.S.), Johnson & Johnson (Biosense Webster) (U.S.), Medtronic PLC. (Ireland), Stereotaxis, Inc. (U.S.), Acutus Medical (U.S.), GE Healthcare (U.S.), Auris Surgical Robotics (Hansen Medical), Microport Scientific Corporation (China), Magnetecs Corporation (U.S.).The report provides an in-depth market analysis of the above-mentioned segments across the following regions:• North America• U.S.• Others• Europe• Germany• U.K.• France• Others• Asia-Pacific• Japan• China• India• Others• Rest of the World (RoW)• Brazil• Rest of Latin América• Middle East & OthersDownload the full report: https://www.reportbuyer.com/product/5476601
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: firstname.lastname@example.org
Tel: +1 (718) 213 4904 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/the-cardiac-electrophysiology-mapping-navigation-and-recording-devices-global-market-is-expected-to-grow-at-mid-single-digit-cagr-to-reach-1-447-3-million-by-2024--300683740.html